
The Myeloma Sessions: Evolving management of myeloma & COVID-19
VJHemOnc Podcast
Advancements in CAR-T and Bi-Specific Therapies for Multiple Myeloma
This chapter explores the potential game-changing advancements in CAR-T and bi-specific therapies for multiple myeloma, including their ability to improve response rates, prolong survival, and potentially cure patients. It also discusses the use of oral agents in tailoring therapy and minimizing risks, especially in the context of the COVID era.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.